TY - JOUR
T1 - Avoidant/restrictive food intake disorder
T2 - Psychopathological similarities and differences in comparison to anorexia nervosa and the general population
AU - Cañas, Laura
AU - Palma, Carol
AU - Molano, Ana M.
AU - Domene, Lola
AU - Carulla-Roig, Marta
AU - Cecilia-Costa, Raquel
AU - Dolz, Montserrat
AU - Serrano-Troncoso, Eduardo
N1 - Publisher Copyright:
© 2020 Eating Disorders Association and John Wiley & Sons Ltd.
PY - 2021/3
Y1 - 2021/3
N2 - Introduction: Avoidant/restrictive food intake disorder (ARFID) categorises patients with selective and/or restrictive eating patterns in the absence of distorted cognition concerning weight, food, and body image. Objective: To examine the sociodemographic and clinical profile of patients with ARFID in comparison to those with anorexia nervosa (AN) and to a non-clinical group (NCG). Method: A descriptive, observational, comparative study made up of three groups (ARFID, AN and NCG). Ninety-nine children and adolescents were analyzed by means of a semi-structured diagnostic interview and questionnaires on depression, anxiety, clinical fears and general psychopathology. Results: The ARFID group was significantly younger (10.8 vs. 14.1 years of age), with a greater proportion of males (60.6% vs. 6.1%), an earlier onset of illness (6.2 vs. 13.4 years of age), and a longer period of evolution of the illness (61.2 vs. 8.4 months) compared to the AN group. Clinically, patients with ARFID showed greater medical (42.4% vs. 12.1%) and psychiatric (81.8% vs. 33.3%) comorbidity—assessed with a semi-structured diagnostic interview—greater clinical fear (p < 0.005), more attention problems (p < 0.005) and fewer symptoms of anxiety and depression (p < 0.005)—measured with self-report questionnaires. Conclusions: ARFID is a serious disorder with a significant impact on the physical and mental health of the pediatric population. Likewise, some of these physical and mental conditions may be a risk factor in developing ARFID. Attention problems and clinical fears in ARFID, and the greater presence of internalised symptoms in AN, were the main differences found in the psychopathological profiles.
AB - Introduction: Avoidant/restrictive food intake disorder (ARFID) categorises patients with selective and/or restrictive eating patterns in the absence of distorted cognition concerning weight, food, and body image. Objective: To examine the sociodemographic and clinical profile of patients with ARFID in comparison to those with anorexia nervosa (AN) and to a non-clinical group (NCG). Method: A descriptive, observational, comparative study made up of three groups (ARFID, AN and NCG). Ninety-nine children and adolescents were analyzed by means of a semi-structured diagnostic interview and questionnaires on depression, anxiety, clinical fears and general psychopathology. Results: The ARFID group was significantly younger (10.8 vs. 14.1 years of age), with a greater proportion of males (60.6% vs. 6.1%), an earlier onset of illness (6.2 vs. 13.4 years of age), and a longer period of evolution of the illness (61.2 vs. 8.4 months) compared to the AN group. Clinically, patients with ARFID showed greater medical (42.4% vs. 12.1%) and psychiatric (81.8% vs. 33.3%) comorbidity—assessed with a semi-structured diagnostic interview—greater clinical fear (p < 0.005), more attention problems (p < 0.005) and fewer symptoms of anxiety and depression (p < 0.005)—measured with self-report questionnaires. Conclusions: ARFID is a serious disorder with a significant impact on the physical and mental health of the pediatric population. Likewise, some of these physical and mental conditions may be a risk factor in developing ARFID. Attention problems and clinical fears in ARFID, and the greater presence of internalised symptoms in AN, were the main differences found in the psychopathological profiles.
KW - anorexia nervosa
KW - anxiety
KW - ARFID
KW - comorbidity
KW - depression
KW - psychopathology
UR - http://www.scopus.com/inward/record.url?scp=85097410016&partnerID=8YFLogxK
U2 - 10.1002/erv.2815
DO - 10.1002/erv.2815
M3 - Article
C2 - 33306214
AN - SCOPUS:85097410016
SN - 1072-4133
VL - 29
SP - 245
EP - 256
JO - European Eating Disorders Review
JF - European Eating Disorders Review
IS - 2
ER -